| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J Thorac Cardiovasc Surg 2008;135:620-626
© 2008 The American Association for Thoracic Surgery
General Thoracic Surgery |
a Thoracic Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY
b Biostatistics Service, Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY
c Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY
d Department of Cardiothoracic Surgery, New York University Medical Center, New York, NY
e Department of Pathology, University of Hawaii, Honolulu, Hawaii
Received for publication May 3, 2007; revisions received September 13, 2007; accepted for publication October 22, 2007. * Address for reprints: Raja M. Flores, MD, Thoracic Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Room C-879, New York, NY 10021. (Email: floresr{at}mskcc.org).
Objective: The optimal procedure for resection of malignant pleural mesothelioma is controversial, partly because previous analyses include small numbers of patients. We performed a multi-institutional study to increase statistical power to detect significant differences in outcome between extrapleural pneumonectomy and pleurectomy/decortication.
Methods: Patients with malignant pleural mesothelioma who underwent extrapleural pneumonectomy or pleurectomy/decortication at 3 institutions were identified. Survival and prognostic factors were analyzed by the Kaplan–Meier method, log-rank test, and Cox proportional hazards analysis.
Results: From 1990 to 2006, 663 consecutive patients (538 men and 125 women) underwent resection. The median age was 63 years (range, 26–93 years). The operative mortality was 7% for extrapleural pneumonectomy (n = 27/385) and 4% for pleurectomy/decortication (n = 13/278). Significant survival differences were seen for American Joint Committee on Cancer stages 1 to 4 (P < .001), epithelioid versus non-epithelioid histology (P < .001), extrapleural pneumonectomy versus pleurectomy/decortication (P < .001), multimodality therapy versus surgery alone (P < .001), and gender (P < .001). Multivariate analysis demonstrated a hazard rate of 1.4 for extrapleural pneumonectomy (P < .001) controlling for stage, histology, gender, and multimodality therapy.
Conclusion: Patients who underwent pleurectomy/decortication had a better survival than those who underwent extrapleural pneumonectomy; however, the reasons are multifactorial and subject to selection bias. At present, the choice of resection should be tailored to the extent of disease, patient comorbidities, and type of multimodality therapy planned.
This article has been cited by other articles:
|
|
 |
|
  M. Shimokawa, S. Hasegawa, K. Fukuoka, M. Okada, K. Yokoi, F. Tanaka, T. Yamanaka, T. Daimon, and T. Nakano A Feasibility Study of Induction Pemetrexed Plus Cisplatin Followed by Pleurectomy/Decortication Aimed at Macroscopic Complete Resection for Malignant Pleural Mesothelioma Jpn. J. Clin. Oncol., May 1, 2013; 43(5): 575 - 578. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Tsutani, T. Takuwa, Y. Miyata, K. Fukuoka, S. Hasegawa, T. Nakano, and M. Okada Prognostic significance of metabolic response by positron emission tomography after neoadjuvant chemotherapy for resectable malignant pleural mesothelioma Ann. Onc., April 1, 2013; 24(4): 1005 - 1010. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ried, T. Potzger, N. Braune, R. Neu, Y. Zausig, B. Schalke, C. Diez, and H.-S. Hofmann Cytoreductive surgery and hyperthermic intrathoracic chemotherapy perfusion for malignant pleural tumours: perioperative management and clinical experience Eur J Cardiothorac Surg, April 1, 2013; 43(4): 801 - 807. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Gelvez-Zapata, D. Gaffney, M. Scarci, and A. S. Coonar What is the survival after surgery for localized malignant pleural mesothelioma? Interact CardioVasc Thorac Surg, April 1, 2013; 16(4): 533 - 537. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Lindenmann, V. Matzi, N. Neuboeck, U. Anegg, A. Maier, J. Smolle, and F. M. Smolle-Juettner Multimodal therapy of malignant pleural mesothelioma: is the replacement of radical surgery imminent? Interact CardioVasc Thorac Surg, March 1, 2013; 16(3): 237 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Waller Lung-sparing total pleurectomy: the surgical option of choice in malignant pleural mesothelioma? Eur J Cardiothorac Surg, February 7, 2013; (2013) ezt022v1. [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ploenes, T. Osei-Agyemang, A. Krohn, C. F. Waller, V. Duncker-Rohr, M. Elze, and B. Passlick Changes in lung function after surgery for mesothelioma Asian Cardiovascular and Thoracic Annals, February 1, 2013; 21(1): 48 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bolukbas, M. Eberlein, N. Kudelin, M. Demes, S. Stallmann, A. Fisseler-Eckhoff, and J. Schirren Factors predicting poor survival after lung-sparing radical pleurectomy of IMIG stage III malignant pleural mesothelioma Eur J Cardiothorac Surg, December 13, 2012; (2012) ezs648v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. PASELLO, G. MARULLI, V. POLO, C. BREDA, L. BONANNO, L. LOREGGIAN, F. REA, and A. FAVARETTO Pemetrexed plus Carboplatin or Cisplatin as Neoadjuvant Treatment of Operable Malignant Pleural Mesothelioma (MPM) Anticancer Res, December 1, 2012; 32(12): 5393 - 5399. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. M. Mollberg, Y. Vigneswaran, H. L. Kindler, C. Warnes, R. Salgia, A. N. Husain, and W. T. Vigneswaran Quality of Life After Radical Pleurectomy Decortication for Malignant Pleural Mesothelioma Ann. Thorac. Surg., October 1, 2012; 94(4): 1086 - 1092. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. S. Al-Alao, H. Parissis, I. J. Rychlik, A. Graham, and J. McGuigan Prognostic factors in malignant pleural mesothelioma: role of talc pleurodesis Asian Cardiovascular and Thoracic Annals, August 1, 2012; 20(4): 443 - 449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bille, L. Okiror, W. Karenovics, J. Pilling, and L. Lang-Lazdunski What is the optimum strategy for thromboembolic prophylaxis following extrapleural pneumonectomy in patients with malignant pleural mesothelioma? Interact CardioVasc Thorac Surg, August 1, 2012; 15(2): 201 - 203. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Lang-Lazdunski, S. Barrington, A. Bille, and P.-Y. Bondiau Cyberknife radiosurgery for focal paravertebral recurrence after radical pleurectomy/decortication in malignant pleural mesothelioma Eur J Cardiothorac Surg, June 1, 2012; 41(6): 1393 - 1394. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Friedberg, M. J. Culligan, R. Mick, J. Stevenson, S. M. Hahn, D. Sterman, S. Punekar, E. Glatstein, and K. Cengel Radical Pleurectomy and Intraoperative Photodynamic Therapy for Malignant Pleural Mesothelioma Ann. Thorac. Surg., May 1, 2012; 93(5): 1658 - 1667. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Nakas, E. v. Meyenfeldt, K. Lau, S. Muller, and D. Waller Long-term survival after lung-sparing total pleurectomy for locally advanced (International Mesothelioma Interest Group Stage T3-T4) non-sarcomatoid malignant pleural mesothelioma Eur J Cardiothorac Surg, May 1, 2012; 41(5): 1031 - 1036. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Chen and M. B. Pace Malignant pleural mesothelioma Am. J. Health Syst. Pharm., March 1, 2012; 69(5): 377 - 385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Hoffmann, A. Ulrich, E. Schloericke, S. Limmer, J. K. Habermann, H. Wolken, H.-P. Bruch, and P. Kujath The application of cold-plasma coagulation on the visceral pleura results in a predictable depth of necrosis without fistula generation Interact CardioVasc Thorac Surg, March 1, 2012; 14(3): 239 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Ettinger, W. Akerley, H. Borghaei, A. Chang, R. T. Cheney, L. R. Chirieac, T. A. D'Amico, T. L. Demmy, A. K. P. Ganti, R. Govindan, et al. Malignant Pleural Mesothelioma J Natl Compr Canc Netw, January 1, 2012; 10(1): 26 - 41. [Full Text] [PDF]
|
|
|
|
|
|
M. D. Schulz, K. A. V. Zubris, J. E. Wade, R. F. Padera, X. Xu, M. W. Grinstaff, and Y. L. Colson Paclitaxel-Loaded Expansile Nanoparticles in a Multimodal Treatment Model of Malignant Mesothelioma Ann. Thorac. Surg., December 1, 2011; 92(6): 2007 - 2014. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Dimitrakakis, T. BinEsmael, A. Szafranek, and P. A. O'Keefe ERRATUM for a missing eComment 'Malignant pleural mesothelioma: a therapeutic challenge' Interact CardioVasc Thorac Surg, December 1, 2011; 13(6): 691 - 692. [Full Text] [PDF]
|
|
|
|
|
|
T. Tokunaga, M. Higashiyama, J. Okami, J. Maeda, A. Fujiwara, and K. Kodama ERRATUM for a missing eComment to 'Intrathoracic chemo-thermotherapy with radiofrequency waves after extrapleural pneumonectomy for malignant pleural mesothelioma': [Interact CardioVasc Thorac Surg 2011;13:267-270] Interact CardioVasc Thorac Surg, October 1, 2011; 13(4): 460 - 461. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Carbone, Y. I. Baris, P. Bertino, B. Brass, S. Comertpay, A. U. Dogan, G. Gaudino, S. Jube, S. Kanodia, C. R. Partridge, et al. Erionite exposure in North Dakota and Turkish villages with mesothelioma PNAS, August 16, 2011; 108(33): 13618 - 13623. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Friedberg, R. Mick, M. Culligan, J. Stevenson, A. Fernandes, D. Smith, E. Glatstein, S. M. Hahn, and K. Cengel Photodynamic Therapy and the Evolution of a Lung-Sparing Surgical Treatment for Mesothelioma Ann. Thorac. Surg., June 1, 2011; 91(6): 1738 - 1745. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sharif, I. Zahid, T. Routledge, and M. Scarci Extrapleural pneumonectomy or supportive care: treatment of malignant pleural mesothelioma? Interact CardioVasc Thorac Surg, June 1, 2011; 12(6): 1040 - 1045. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Nasu, M. Carbone, G. Gaudino, B. H. Ly, P. Bertino, D. Shimizu, P. Morris, H. I. Pass, and H. Yang Ranpirnase Interferes with NF-{kappa}B Pathway and MMP9 Activity, Inhibiting Malignant Mesothelioma Cell Invasiveness and Xenograft Growth Genes & Cancer, May 1, 2011; 2(5): 576 - 584. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Zahid, S. Sharif, T. Routledge, and M. Scarci Is pleurectomy and decortication superior to palliative care in the treatment of malignant pleural mesothelioma? Interact CardioVasc Thorac Surg, May 1, 2011; 12(5): 812 - 817. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Rena and C. Casadio Lack of evidence in malignant pleural mesothelioma surgery Interact CardioVasc Thorac Surg, March 1, 2011; 12(3): 347 - 348. [Full Text] [PDF]
|
|
|
|
|
|
Y. Shahin, J. Wellham, R. Jappie, K. Pointon, A. Majewski, and E. Black How successful is lung-preserving radical surgery in the mesothelioma and radical surgery-trial environment? A case-controlled analysis Eur J Cardiothorac Surg, March 1, 2011; 39(3): 360 - 363. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Teh, F. Fiorentino, C. Tan, and T. Treasure A systematic review of lung-sparing extirpative surgery for pleural mesothelioma Journal of the Royal Society of Medicine, February 1, 2011; 104(2): 69 - 80. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. B. Watzka, U. Setinek, E. B. Stubenberger, M. Totsch, G. Dekan, M. Marcher, T. Fleck, and M. R. Muller Integrin-linked kinase, phosphorylated AKT and the prognosis of malignant pleural mesothelioma Eur J Cardiothorac Surg, February 1, 2011; 39(2): 180 - 184. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kawamukai, F. Antonacci, S. Di Saverio, and M. Boaron Acute postoperative cardiac herniation Interact CardioVasc Thorac Surg, January 1, 2011; 12(1): 73 - 74. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. E. Van Schil, P. Baas, R. Gaafar, A. P. Maat, M. Van de Pol, B. Hasan, H. M. Klomp, A. M. Abdelrahman, J. Welch, J. P. van Meerbeeck, et al. Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial Eur. Respir. J., December 1, 2010; 36(6): 1362 - 1369. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Weder Mesothelioma Ann. Onc., October 1, 2010; 21(suppl_7): vii326 - vii333. [Full Text] [PDF]
|
|
|
|
|
|
A. S. Wolf, W. G. Richards, T. R. Tilleman, L. Chirieac, S. Hurwitz, R. Bueno, and D. J. Sugarbaker Characteristics of Malignant Pleural Mesothelioma in Women Ann. Thorac. Surg., September 1, 2010; 90(3): 949 - 956. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Creaney, N. J. Olsen, F. Brims, I. M. Dick, A. W. Musk, N. H. de Klerk, S. J. Skates, and B. W. S. Robinson Serum Mesothelin for Early Detection of Asbestos-Induced Cancer Malignant Mesothelioma Cancer Epidemiol. Biomarkers Prev., September 1, 2010; 19(9): 2238 - 2246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Utley, F. Fiorentino, and T. Treasure Obtaining an upper estimate of the survival benefit associated with surgery for mesothelioma, Eur J Cardiothorac Surg, September 1, 2010; 38(3): 241 - 244. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Weder, I. Opitz, and R. Stahel Surgery and multimodality treatment for malignant pleural mesothelioma Thoracic Malignancies, June 10, 2010; 407 - 418. [Abstract] [Fulltext] [PDF]
|
|
|
|
|
|
M. Hoffmann, H.-P. Bruch, P. Kujath, and S. Limmer Cold-plasma coagulation in the treatment of malignant pleural mesothelioma: results of a combined approach Interact CardioVasc Thorac Surg, April 1, 2010; 10(4): 502 - 505. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Lucchi, A. Picchi, G. Ali, A. Chella, G. Guglielmi, A. Cristaudo, G. Fontanini, and A. Mussi Multimodality treatment of malignant pleural mesothelioma with or without immunotherapy: does it change anything? Interact CardioVasc Thorac Surg, April 1, 2010; 10(4): 572 - 576. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Balduyck, D. Trousse, A. Nakas, A. E. Martin-Ucar, J. Edwards, and D. A. Waller Therapeutic Surgery for Nonepithelioid Malignant Pleural Mesothelioma: Is it Really Worthwhile? Ann. Thorac. Surg., March 1, 2010; 89(3): 907 - 911. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Treasure Surgery for mesothelioma: MARS landing and future missions Eur J Cardiothorac Surg, March 1, 2010; 37(3): 509 - 510. [Full Text] [PDF]
|
|
|
|
|
|
D. Rice Invited Commentary Ann. Thorac. Surg., January 1, 2010; 89(1): 210 - 211. [Full Text] [PDF]
|
|
|
|
|
|
D. S. Trousse, J.-P. Avaro, X. B. D'Journo, C. Doddoli, P. Astoul, R. Giudicelli, P. A. Fuentes, and P. A. Thomas Is malignant pleural mesothelioma a surgical disease? A review of 83 consecutive extra-pleural pneumonectomies Eur J Cardiothorac Surg, October 1, 2009; 36(4): 759 - 763. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Rice, M. A. Steliga, J. Stewart, G. Eapen, C. A. Jimenez, J. H. Lee, W. L. Hofstetter, E. M. Marom, R. J. Mehran, A. A. Vaporciyan, et al. Endoscopic Ultrasound-Guided Fine Needle Aspiration for Staging of Malignant Pleural Mesothelioma Ann. Thorac. Surg., September 1, 2009; 88(3): 862 - 869. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. P Currie, S. J Watt, and N. A Maskell An overview of how asbestos exposure affects the lung BMJ, August 24, 2009; 339(aug24_1): b3209 - b3209. [Full Text]
|
|
|
|
 |
|
 T. R. Tilleman, W. G. Richards, L. Zellos, B. E. Johnson, M. T. Jaklitsch, J. Mueller, B. Y. Yeap, A. A. Mujoomdar, C. T. Ducko, R. Bueno, et al. Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study. J. Thorac. Cardiovasc. Surg., August 1, 2009; 138(2): 405 - 411. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Krug, H. I. Pass, V. W. Rusch, H. L. Kindler, D. J. Sugarbaker, K. E. Rosenzweig, R. Flores, J. S. Friedberg, K. Pisters, M. Monberg, et al. Multicenter Phase II Trial of Neoadjuvant Pemetrexed Plus Cisplatin Followed by Extrapleural Pneumonectomy and Radiation for Malignant Pleural Mesothelioma J. Clin. Oncol., June 20, 2009; 27(18): 3007 - 3013. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Gordon, L. Dong, B. Y. Yeap, W. G. Richards, J. N. Glickman, H. Edenfield, M. Mani, R. Colquitt, G. Maulik, B. Van Oss, et al. Four-Gene Expression Ratio Test for Survival in Patients Undergoing Surgery for Mesothelioma J Natl Cancer Inst, May 6, 2009; 101(9): 678 - 686. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. D. Yan, M. Boyer, M. M. Tin, J. Sim, C. Kennedy, J. McLean, P. G. Bannon, and B. C. McCaughan Prognostic Features of Long-term Survivors After Surgical Management of Malignant Pleural Mesothelioma Ann. Thorac. Surg., May 1, 2009; 87(5): 1552 - 1556. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Tsao, I. Wistuba, J. A. Roth, and H. L. Kindler Malignant Pleural Mesothelioma J. Clin. Oncol., April 20, 2009; 27(12): 2081 - 2090. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. de Perrot, R. Feld, B.C. J. Cho, A. Bezjak, M. Anraku, R. Burkes, H. Roberts, M. S. Tsao, N. Leighl, S. Keshavjee, et al. Trimodality Therapy With Induction Chemotherapy Followed by Extrapleural Pneumonectomy and Adjuvant High-Dose Hemithoracic Radiation for Malignant Pleural Mesothelioma J. Clin. Oncol., March 20, 2009; 27(9): 1413 - 1418. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Ampollini, A. Soltermann, E. Felley-Bosco, D. Lardinois, S. Arni, R. F. Speck, W. Weder, and I. Opitz Immuno-chemotherapy reduces recurrence of malignant pleural mesothelioma: an experimental setting Eur J Cardiothorac Surg, March 1, 2009; 35(3): 457 - 462. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Nakas, D. S. Trousse, A. E. Martin-Ucar, and D. A. Waller Open lung-sparing surgery for malignant pleural mesothelioma: the benefits of a radical approach within multimodality therapy Eur J Cardiothorac Surg, October 1, 2008; 34(4): 886 - 891. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
